Materials Letters
journal homepage: www.elsevier.com/locate/matlet
Instituto de Arquitectura, Diseo y Arte, Universidad Autnoma de Cd. Jurez, Av. Del Charro 450 Norte, Col. Universidad, C.P. 32310 Cd. Jurez, Chihuahua,
Mexico
b
Instituto de Ingeniera y Tecnologa, Universidad Autnoma de Cd. Jurez, Av. Del Charro 450 Norte, Col. Universidad, C.P. 32310, Cd. Jurez, Chihuahua,
Mexico
c
ICTP Meso-American Centre for Theoretical Physics (ICTP-MCTP)/Universidad Autnoma de Chiapas, Ciudad Universitaria, Carretera Zapata Km. 4, Real del
Bosque (Tern), Tuxtla Gutirrez, Chiapas, C.P. 29040, Mexico
art ic l e i nf o
a b s t r a c t
Article history:
Received 7 August 2013
Accepted 4 January 2014
Available online 10 January 2014
[Porous biocomposite scaffolds of Chitosan/Mimosa tenuiora (Ch/Mim) were fabricated for tissue
engineering applications by thermally induced phase separation and lyophilization techniques. The
in vitro bioactivity evaluation of the scaffolds was carried out by analyzing the apatite layers produced on
them using SBF as the incubation medium. The apatite formation was analyzed using FTIR spectroscopy
and Field Emission Scanning Electron microscopy coupled to Energy-Dispersive Electron X-ray Spectroscopy. The cumulative results obtained from IR spectra and SEM-EDS suggest that the developed
composites might have potential applications in tissue engineering.
& 2014 Elsevier B.V. All rights reserved.
Keywords:
Bioactive materials
Chitosan
Mimosa tenuiora
SBF
1. Introduction
Mimosa tenuiora (Willd.) Poiret is a species of the Mimosoideae, a subfamily of the Fabaceae botanical family that is
distributed from Mexico to Venezuela and Brazil [1]. It is a plant
with a high content in tannins and large amount of starch [2].
M. tenuiora is traditionally used as an aqueous extract [3] for the
treatment in wounds and venous leg ulcers due to its healing and
antiseptic properties [4]. It has been used in the treatment of
burns and infections in both humans and animals because of its
antimicrobial and cicatrizing effects [4,5].
The chemical composition of the M. tenuiora cortex has been
identied as a group of alkaloids, mainly N-N-dimethyltryptamine,
serotonin, triperpenoid glycosides, and steroidal saponins: 3-O-D-glucopiranosil campesterol, 3-O--D-glucopiranosil estigmasterol, and 3-O--D-glucopiranosil -sitosterol [4].
On the other hand, Chitosan is a semi-crystalline polysaccharide
derived from chitin and possesses antimicrobial activity [6]. Due to
its properties, Chitosan is a good candidate for preparation of
biomaterials that could substitute missing or damaged tissue [7].
One of the most important characteristics of a bioactive material
is the possibility that a biologically active carbonate hydroxyapatite
0167-577X/$ - see front matter & 2014 Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.matlet.2014.01.004
layer can form on their surface [8]. Calcium phosphate is the main
constituent of bone tissue [9]. This substance could be formed on the
material surface by an inorganic chemical reaction similar to that
occurring in bones. This ability has been related to osteoconduction
and bone bonding [10], because the properties of the apatite layer
can affect cell viability and proliferation [8]. In order to predict
bioactivity, a simulated body uid (SBF) has been used [11].
With these characteristics, it could be reasonable to believe in
the bioactivity of a Chitosan/M. tenuiora composite. So, in this
study, a biocomposite of Chitosan/M. tenuiora composite was
manufactured through a thermally induced phase separation
method. The composite was used to investigate the in vitro
bioactivity of scaffolds by analyzing the apatite layers produced
in them using SBF as an incubation medium.
2. Materials and methods
Materials: Chitosan was purchased from Carbomer, Inc (United
States). The bark of M. tenuiora was obtained directly in the
region of Jiquipilas Chiapas. Ethanol was provided by CTR Scientic
(Mexico). Glacial acetic acid (Mallinckrodt, United States) was used
as a solvent. SBF was prepared in our laboratory according to a
previously published method [7].
Preparation of composites: Chitosan/M. tenuiora was prepared
using the thermally induced phase separation technique. Briey,
147
Fig. 1. FTIR spectra of Mimosa tenuiora, Chitosan and 80/20 Ch/Mimosa tenuiora composite before incubation.
Table 1
Pore size distribution. It shows the average pore size (mm) and the distribution of porosity in Chitosan and 80/20 Chitosan/Mimosa tenuiora.
Composite
o50 mm (%)
50100 mm (%)
100200 mm (%)
200300 mm (%)
300400 mm (%)
400500 mm (%)
4500 mm (%)
Chitosan
80/20 Ch/Mim
150.56 714.65
211.61 713.74
15
12
30
16
35
24
10
22
4
12
1
12
5
2
148
Fig. 2. SEM micrographs exhibit (a) Chitosan/Mimosa tenuiora composite and (b) Chitosan scaffold without any treatment. Then, the gure shows the Chitosan/Mimosa
tenuiora scaffolds at 21 days of SBF treatment at (c) 600 , (d) Chitosan at 28 days at 1000 and Chitosan/Mimosa tenuiora at 28 days of treatment at (e) 1000 and
(f) 1700 .
Fig. 3. FTIR of the (a) Chitosan/Mimosa tenuiora composite before the treatment and (b) Chitosan and (c) Chitosan/Mimosa tenuiora composite immersed for 28 days in
1.5 SBF. The image shows evidence of carbonate (CO23 ). Also the FTIR spectra revealed the presence of the v3 stretching mode of PO bonds.
Acknowledgments
The authors acknowledge the nancial support of the Mexican
Public Education Secretary and the Mexican National Council for
149
References
[1] Anton R, Jiang Y, Weniger B, Beck J, Rivier L. Pharmacognosy of Mimosa
tenuiora (Willd.) Poiret. J Ethnopharmacol 1993;38:1537.
[2] Sousa T, Leal N, Cavalcanti E, Alburquerque U. A new approach to study
medicinal plants with tannins and avonoids contents from the local knowledge. J Ethnopharmacol 2008;12:7280.
[3] Zippel J, Deters A, Hensel A. Arabinogalactans from Mimosa tenuiora (Willd).
Poiret bark as active principles for wound healing properties: specic
enhancement of dermal broblast activity and minor inuence on HaCaT
keratinocytes. J Ethnopharmacol 2009;124:3916.
[4] Lammogllia-Ordiales L, Vega.Memije M, Herrera-Arellano A, Rivera-Arce E,
Agero J, Vargas-Martnez F, et al. A randomised comparative trial on the use
of a hydrogel with tepescohuite extract (Mimosa tenuiora cortex extract-2G)
in the treatment of venous leg ulcers. Int Wound J 2011;9:4128.
[5] Pimentel E, Cruces M, Zimmering S. Evaluation of the mutagenic potential of
tepezcohuite in the Drosphila wing spot test. Mutat Res 1991;264:1156.
[6] Martnez-Camacho A, Cortez-Rocha M, Ezquerra-Brauer J, Graciano-Verdugo
A, Rodrguez-Flix F, Castillo-Ortega M, et al. Chitosan composite lms:
thermal, structural, mechanical and antifungal properties. Carbohydr Polym
2010;82:30515.
[7] Martel-Estrada S, Martnez-Prez C, Chacn-Nava J, Garca-Casillas P, OlivasArmendriz I. In vitro bioactivity of Chitosan/poly(D,L-lactide-co-glycolide)
composites. Mater Lett 2011;65:13741.
[8] Kong L, Gao Y, Lu G, Gong Y, Zhao N, Zhang X. A study on the bioactivity of
Chitosan/nano-hydroxyapatite composite scaffolds for bone tissue engineering. Eur Polym J 2006;42:31719.
[9] Martel-Estrada S, Olivas-Armendriz I, Martnez-Prez C, Hernndez T, AcostaGmez E, Chacn-Nava J, et al. Chitosan/poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. J Mater Sci 2012;23:2893901.
[10] Peltola T, Jokinen M, Veittola S, Simola J, Yli-Urpo A. In vitro bioactivity and
structural features of mildly heat-treated solgel-derived silica bers.
J Biomed Mater Res 2000;54:57990.
[11] Lee K, Rhee S. The mechanical properties and bioactivity of poly(methyl
methacrylate)/SiO2CaO nanocomposite. Biomaterials 2009;30:34449.
[12] Jones A, Arns C, Hutmacher D, Milthorpe B, Sheppard A, Knackstedt M. The
correlation of pore morphology, interconnectivity and physical properties of
3D ceramic scaffolds with bone ingrowth. Biomaterials 2009;30:144051.